Ara h 1 Peptide Immunotherapy Ameliorates Peanut-Induced Anaphylaxis

Ara h 1 Peptide Immunotherapy Ameliorates Peanut-Induced Anaphylaxis

Conclusions The ability of peptide immunotherapy to ameliorate signs and symptoms of anaphylaxis in an experimental, murine model supports the further evaluation of this form of therapy in clinical peanut allergy.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2015-02, Vol.135 (2), p.AB158-AB158
Hauptverfasser: Simms, Elizabeth, MSc, Rudulier, Christopher, Wattie, Jennifer, Kwok, William W., PhD, James, Eddie A., PhD, Moldaver, Daniel M, Jordana, Manel, MD, PhD, Larché, Mark, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Allergies
Allergy and Immunology
Food allergies
Immunotherapy
Peptides
Rodents
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Conclusions The ability of peptide immunotherapy to ameliorate signs and symptoms of anaphylaxis in an experimental, murine model supports the further evaluation of this form of therapy in clinical peanut allergy.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2014.12.1456